Due to the high incidence and recurrence rate non-muscle invasive bladder cancer (NMIBC) has a relevant impact. Raman spectroscopy and optical coherence tomography represent innovative diagnostic tools. Urine markers still play a minor role in the diagnostics of NMIBC. New therapeutic options are thermochemotherapy and mitomycin-C electromotive drug administration (MMC-EMDA) as well as gemcitabine and apaziquone for intravesical administration.
Written by:
Sommerauer M, Jocham D, Laturnus JM Are you the author?
Klinik und Poliklinik für Urologie, UK-SH Campus Lübeck, Ratzeburgerallee 160, 23568, Lübeck, Deutschland, .
Reference: Urologe A. 2012 Jun;51(6):791-7
doi: 10.1007/s00120-012-2897-3
PubMed Abstract
PMID: 22618669
[Article in German]